Table 1.
Relationship between methyltransferase 3 (METTL3) expression and the clinicopathological characteristics of the studied patient groups
| Variable | Total | METTL3 | P value | |
|---|---|---|---|---|
| Negative (n=134) | Positive (n=47) | |||
| Age | 0.662 | |||
| <60 | 57 | 41 (71.9) | 16 (28.1) | |
| ≥60 | 124 | 93 (75.0) | 31 (25.0) | |
| Gender | 0.949 | |||
| Male | 97 | 72 (74.2) | 25 (25.8) | |
| Female | 84 | 62 (73.8) | 22 (26.2) | |
| Tumor size | 0.031 | |||
| ≤15 | 91 | 61 (67.0) | 30 (33.0) | |
| >15 | 90 | 73 (81.1) | 17 (18.9) | |
| Metastasis | 0.002 | |||
| Tumor metastasis | 7 | 0 (0.0) | 7 (100.0) | |
| No metastasis | 174 | 134 (77.0) | 40 (23.0) | |
| Histological grade | 0.601 | |||
| I–II | 158 | 118 (74.7) | 40 (25.3) | |
| III–IV | 23 | 16 (69.6) | 7 (30.4) | |
| Tumor stage | 0.734 | |||
| T1–T2 | 17 | 12 (70.6) | 5 (29.4) | |
| T3–T4 | 164 | 122 (74.3) | 42 (25.6) | |
Notes: Bold: P<0.05, P values were two-tailed and based on Pearson Chi-square test.